Section 1 Short title
This Act may be cited as the “Protecting Equal Access to Thyroid Act of 2026” or the “PEAT Act of 2026”.
Protecting Equal Access to Thyroid Act of 2026
A BILL
To amend the Public Health Service Act to prohibit treatment of a biologic as a biological product based solely on the presence of a protein that is a clinically inactive component in such biologic, and for other purposes.
Sec. 2 Prohibition with respect to treatment of proteins in biologics
by striking “The term” and inserting the following:
“(A) The term”
by adding at the end the following:
“(B) A biologic described in subparagraph (A) may not be treated as a biological product based solely on the presence of a protein that is a clinically inactive component in such biologic.”
Technical correction— Section 351(i)(1) of the Public Health Service Act (42 U.S.C. 262(i)(1)) is amended in subparagraph (A), as designated by subsection (a)(1), by striking “protein ,” and inserting “protein,”.